Warning: Compliance "Weaponization" in the UK Herbal Category
Hi everyone,
I’m seeing a worrying trend in the UK supplement space that I felt was important to share with the community.
While we all expect the Amazon "bots" to flag listings for Novel Food status (like Lion's Mane) or medicinal claims, there is a shift toward competitor-led reporting.
Savvy sellers are now auditing high-ranking competitor listings for technical UK compliance errors—missing mandatory warnings or unauthorized extracts—and reporting them directly via Brand Registry. Because Amazon is risk-averse, these reports often trigger immediate suspensions and lengthy "red tape" for reinstatement.
As someone deep in the herbal space, my advice is to proactively audit your labels and COAs against current FSA/MHRA guidelines. Don't assume that because your listing is active today, it’s "safe"—an error in your bullet points is a vulnerability a competitor can use to take you off the board.
I’ve spent a lot of time navigating these specific regulatory hurdles lately. If you're seeing similar "targeted" flags, I'm happy to discuss the trends here.
Best,
[Peter Raftery/Scripts of Nature]
Warning: Compliance "Weaponization" in the UK Herbal Category
Hi everyone,
I’m seeing a worrying trend in the UK supplement space that I felt was important to share with the community.
While we all expect the Amazon "bots" to flag listings for Novel Food status (like Lion's Mane) or medicinal claims, there is a shift toward competitor-led reporting.
Savvy sellers are now auditing high-ranking competitor listings for technical UK compliance errors—missing mandatory warnings or unauthorized extracts—and reporting them directly via Brand Registry. Because Amazon is risk-averse, these reports often trigger immediate suspensions and lengthy "red tape" for reinstatement.
As someone deep in the herbal space, my advice is to proactively audit your labels and COAs against current FSA/MHRA guidelines. Don't assume that because your listing is active today, it’s "safe"—an error in your bullet points is a vulnerability a competitor can use to take you off the board.
I’ve spent a lot of time navigating these specific regulatory hurdles lately. If you're seeing similar "targeted" flags, I'm happy to discuss the trends here.
Best,
[Peter Raftery/Scripts of Nature]
1 reply
Seller_SDOeQOuw4YXKJ
You're absolutely right that competitor-driven reporting has become more common, especially in regulated categories like supplements. Many sellers focus mainly on ranking and advertising but overlook regulatory compliance in their listings and labels.
I’ve seen cases where even small issues such as wording around health benefits, missing warnings, or unclear ingredient references triggered suspensions after a report. Because Amazon often acts quickly in these situations, it’s important to review both the physical packaging and the listing content against FSA and MHRA guidance regularly.
A proactive compliance audit can save a lot of trouble later. I am curious if others here have seen similar competitor-driven reports recently
